Rohto Pharmaceutical Co., Ltd. (4527)
Market Closed
10 Aug, 06:00
JPX 
¥
2,828. 00
-34.5
-1.2052%
¥
571.8B Market Cap
- P/E Ratio
0.27% Div Yield
3.4M Volume
- Eps
¥ 2,862.5
Previous Close Want to track 4527 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rohto Pharmaceutical Co., Ltd. (4527) Statistics
Valuation metrics
Market Cap 571.8B
Enterprise value 620.25B
Trailing P/E (ttm) 18.89
Forward P/E 14.32
PEG ratio 1.69
Price/Sales (ttm) 1.88
Price/Book (mrq) 2.14
Enterprise Value/Revenue 1.8
Enterprise Value/EBITDA 9.47
Overview
Shares outstanding 225.96M
Float 200.75M
Shares short -
% Held by insiders 0.1%
% Held by institutions 0.38%
Average volume (10 days) 2.23M
Average volume (90 days) 1.1M
Price summary
52-Week low 2,218.5
52-Week high 2,918.5
Beta -0.47
50-Day moving average 2,417.73
200-Day moving average 2,428.11
Dividends and splits
Forward annual dividend rate 46
Forward annual dividend yield 0.0191%
Trailing annual dividend rate 46
Trailing annual dividend yield 0.0161%
5-Year annual dividend yield 1.04%
Payout ratio 0.26
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 2:1
Last split Date 29 Dec 2022
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.1%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.12%
Income Statement
Revenue (ttm) 335.8B
Revenue per share (ttm) 1,520.89
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 188.49B
EBITDA 54.85B
Net income to common (ttm) 34.54B
Diluted EPS (ttm) 151.54
Quarterly earnings growth (yoy) -0.11%
Balance Sheet
Total cash (mrq) 74.1B
Total cash per share (mrq) 384.14
Total debt (mrq) 51.79B
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 2.04%
Book value per share (mrq) 1,416.7
Cash Flow
Cash flow statement 36.82B
Levered free cash flow (LFCF) 31.01B
